Avalo Therapeutics Stock Forecast

Buy or Hold candidate since Jun 22, 2026 Gain 6.85%

The Avalo Therapeutics, Inc. stock price fell by -5.88% on the last day (Friday, 31st Jul 2026) from $19.39 to $18.25. During the last trading day the stock fluctuated 8.17% from a day low at $18.24 to a day high of $19.73. The price has been going up and down for this period, and there has been a -5.78% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -46 thousand shares and in total, 886 thousand shares were bought and sold for approximately $16.17 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 8.13% during the next 3 months and, with a 90% probability hold a price between $14.99 and $26.63 at the end of this 3-month period.

AVTX Signals & Forecast

The Avalo Therapeutics, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $18.84. On a fall, the stock will find some support from the long-term average at approximately $17.95. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, July 06, 2026, and so far it has fallen -8.57%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Avalo Therapeutics, Inc. stock

Avalo Therapeutics, Inc. finds support from accumulated volume at $18.20 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.49 between high and low, or 8.17%. For the last week, the stock has had daily average volatility of 6.78%.

Our recommended stop-loss: $17.47 (-4.25%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 19 days ago.)

Trading Expectations (AVTX) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Avalo Therapeutics, Inc. to open at $18.74, and during the day (based on 14 day Average True Range), to move between $17.63 and $18.87, which gives a possible trading interval of +/-$1.23 (+/-6.99%) up or down from last closing price. If Avalo Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 6.99% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $18.20 (0.27%) than the resistance at $19.01 (4.16%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Avalo Therapeutics, Inc. stock A Buy?

Avalo Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.796 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $18.74 ( 2.68%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk